Life Sciences

Karyopharm Therapeutics Inc., a clinical-stage Natick firm that's developing a cutting-edge cancer treatment drug, has completed a Series B round of financing that will take the biotechnology startup to the next level.

Arrhythmia Research Technology Inc. of Fitchburg said it will not be able to file its quarterly report for the quarter ending March 31 due to an ongoing internal review by an audit committee and the company's independent auditor.

Framingham-based AB SCIEX, a global analytical technology company, announced the launch of a series of spectrometry-based systems for use in European clinical diagnostic laboratories, the company said.

Chane Graziano, the CEO of Holliston-based Harvard Bioscience Inc., has resigned for personal reasons after 17 years in that role and will retire, the company's directors announced today.

Biotech startup RXi Pharmaceuticals of Westborough, which is pushing ahead with clinical trials for its first product, reported a $14.4-million loss during the first quarter, but saw $100,000 in revenue, compared with no revenue during the first quarter of 2012.

Can Worcester's competitive advantage in life sciences be measured? Four students from Worcester Polytechnic Institute recently set...

A flourishing life sciences industry has created a practical problem for companies that need to protect precious samples: how to store them.

A tracheal scaffold and bioreactor system manufactured by Holliston-based Harvard Bioscience were used in the first successful transplant of a regenerated trachea in the United States, the company announced.

Since 2009, Reflectance Medical in Westborough has been working with a lean team and millions in federal...

The Worcester-based contract research company Averica Discovery Services announced a collaboration with Worcester Polytechnic Institute's Department of Chemistry and Biochemistry that will allow the two organizations to share expertise on projects.